President and Chief Executive Officer · Solid Biosciences Inc. (SLDB)

Ilan Ganot

A named executive officer of Solid Biosciences in every fiscal year CompBrief holds from FY2017 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,293,809

Salary $551,100Stock awards $0Bonus $187,925

FY2020: $1,481,002

1st of 3 named executive officers at Solid Biosciences by FY2021 total.

3 named officers on file for Solid Biosciences, FY2021

Ilan Ganot’s pay file — $29

  • 5 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Solid Biosciences’s whole pay program stands against its peers

  • Solid Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SLDB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Ilan Ganot’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Ilan Ganot compensation by year

Solid Biosciences Summary Compensation Table · all 5 fiscal years held
In US dollars, as Solid Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021
Salary$400,000$450,000$520,000$535,000$551,100
Bonus$200,000$247,500$193,050$294,250$187,925
Stock awards$0$0$0$246,370$0
Option awards$0$5,286,270$2,622,879$405,382$2,544,780
Non-equity incentive$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0
All other$0$0$0$0$10,004
Total$600,000$5,983,770$3,335,929$1,481,002$3,293,809

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Solid Biosciences Inc. DEF 14A filed April 28, 2022, accession 0001193125-22-125475, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Solid Biosciences Inc. filed document, accession 0001193125-22-125475. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.

$600K
$6.0M
$3.3M
$1.5M
$3.3M
FY17
FY18
FY19
FY20
FY21
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option77,500—$22.93
Option106,500—$3.47
Option438,000—$6.80
Option48,250—$37.89

Per the Outstanding Equity Awards at Fiscal Year-End table in Solid Biosciences Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

34 Form 4 lines since the FY2021 proxy (filed April 28, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-10-01Grant or award derivative—150,000$0.00150,000
2026-06-10Grant or award derivative—77,500$0.0077,500
2026-02-18Sale10b5-12,658$5.8227,474
2026-02-13Exercise or conversion derivative10b5-14,861$0.009,722
2026-02-13Exercise or conversion10b5-14,861—30,132
2026-02-04Sale10b5-17,205$6.4425,271
2026-01-31Exercise or conversion10b5-115,000—32,476
2026-01-31Exercise or conversion derivative10b5-115,000$0.0045,000

The 8 most recent of 34 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Solid Biosciences’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Ilan Ganot · this pagePresident and Chief Executive Officer$3,293,809
Erin BrennanChief Legal Officer$2,878,244
Joel SchneiderChief Operating Officer$1,702,761

Board service

Solid Biosciences board · FY2023–FY2025
Director compensation in US dollars, as Solid Biosciences reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$40,000—$297,685$0$337,685
FY2024$40,000$0$224,204$241,145$505,349
FY2023$40,000$0$54,221$807,867$902,088

Each year as the company reported it in Solid Biosciences's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Solid Biosciences pays directors a $40,000 cash retainer and $297,685 in equity. As stated in Solid Biosciences's FY2025 proxy.

The full Solid Biosciences compensation record

free company brief

This page is one person within Solid Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Solid Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ilan Ganot's compensation dossier · One-time report. No refunds.